Minimal clinically important improvement (MCII) and patient-acceptable symptom state (PASS) in total hip arthroplasty (THA) patients 1 year postoperatively

被引:126
|
作者
Paulsen, Aksel [1 ]
Roos, Ewa M. [2 ]
Pedersen, Alma B. [3 ]
Overgaard, Soren [1 ]
机构
[1] Univ Southern Denmark, Inst Clin Res, Odense Univ Hosp, Dept Orthopaed Surg & Traumatol, Odense, Denmark
[2] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Res Unit Musculoskeletal Funct & Physiotherapy, Odense, Denmark
[3] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark
关键词
IMPORTANT-DIFFERENCE; REPORTED OUTCOMES; RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; ANKYLOSING-SPONDYLITIS; OSTEOARTHRITIS; RESPONSIVENESS; REPLACEMENT; EQ-5D; KNEE;
D O I
10.3109/17453674.2013.867782
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background and purpose - The increased use of patient-reported outcomes (PROs) in orthopedics requires data on estimated minimal clinically important improvements (MCIIs) and patient-acceptable symptom states (PASSs). We wanted to find cut-points corresponding to minimal clinically important PRO change score and the acceptable postoperative PRO score, by estimating MCII and PASS 1 year after total hip arthroplasty (THA) for the Hip Dysfunction and Osteoarthritis Outcome Score (HOOS) and the EQ-5D. Patients and methods - THA patients from 16 different departments received 2 PROs and additional questions preoperatively and 1 year postoperatively. The PROs included were the HOOS subscales pain (HOOS Pain), physical function short form (HOOS-PS), and hip-related quality of life (HOOS QoL), and the EQ-5D. MCII and PASS were estimated using multiple anchor-based approaches. Results - Of 1,837 patients available, 1,335 answered the preoperative PROs, and 1,288 of them answered the 1-year follow-up. The MCIIs and PASSs were estimated to be: 24 and 91 (HOOS Pain), 23 and 88 (HOOS-PS), 17 and 83 (HOOS QoL), 0.31 and 0.92 (EQ-5D Index), and 23 and 85 (EQ-VAS), respectively. MCIIs corresponded to a 38-55% improvement from mean baseline PRO score and PASSs corresponded to absolute follow-up scores of 57-91% of the maximum score in THA patients 1 year after surgery. Interpretation - This study improves the interpretability of PRO scores. The different estimation approaches presented may serve as a guide for future MCII and PASS estimations in other contexts. The cutoff points may serve as reference values in registry settings.
引用
收藏
页码:39 / 48
页数:10
相关论文
共 50 条
  • [1] MINIMAL CLINICALLY IMPORTANT IMPROVEMENT (MCII) AND PATIENT ACCEPTABLE SYMPTOM STATE (PASS) FOR PAIN AND FUNCTION INSTRUMENTS IN HAND OSTEOARTHRITIS (OA)
    Kroon, F.
    Van de Stadt, L.
    Van der Heijde, D.
    Kloppenburg, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 304 - 305
  • [2] Minimal clinically important improvement/difference (MCII/MCID) and patient acceptable symptom state (PASS): what do these concepts mean?
    Kvien, Tore K.
    Heiberg, Turid
    Hagen, Kare B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 40 - 41
  • [3] Changes and thresholds in the Forgotten Joint Score after total hip arthroplasty MINIMAL CLINICALLY IMPORTANT DIFFERENCE, MINIMAL IMPORTANT AND DETECTABLE CHANGES, AND PATIENT-ACCEPTABLE SYMPTOM STATE
    Robinson, P. G.
    MacDonald, D. J.
    Macpherson, G. J.
    Patton, J. T.
    Clement, N. D.
    [J]. BONE & JOINT JOURNAL, 2021, 103B (12): : 1759 - 1765
  • [4] Total Hip Arthroplasty: Minimal Clinically Important Difference and Patient Acceptable Symptom State for the Forgotten Joint Score 12
    Longo, Umile Giuseppe
    De Salvatore, Sergio
    Piergentili, Ilaria
    Indiveri, Anna
    Di Naro, Calogero
    Santamaria, Giulia
    Marchetti, Anna
    De Marinis, Maria Grazia
    Denaro, Vincenzo
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (05) : 1 - 11
  • [5] Minimal clinically important difference (MCID), substantial clinical benefit (SCB), and patient-acceptable symptom state (PASS) in patients who have undergone total knee arthroplasty: a systematic review
    Migliorini, Filippo
    Maffulli, Nicola
    Schaefer, Luise
    Simeone, Francesco
    Bell, Andreas
    Hofmann, Ulf Krister
    [J]. KNEE SURGERY & RELATED RESEARCH, 2024, 36 (01)
  • [6] The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis
    Kviatkovsky, Milla Johanna
    Ramiro, Sofia
    Landewe, Robert
    Dougados, Maxime
    Tubach, Florence
    Bellamy, Nicholas
    Hochberg, Marc
    Ravaud, Philippe
    Martin-Mola, Emilio
    Awada, Hassane
    Bombardier, Claire
    Felson, David
    Hajjaj-Hassouni, Najia
    Logeart, Isabelle
    Matucci-Cerinic, Marco
    van de Laar, Mart
    van der Heijde, Desiree
    [J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (09) : 1680 - 1686
  • [7] Minimal clinically important difference (MCID), substantial clinical benefit (SCB), and patient-acceptable symptom state (PASS) in patients who have undergone total knee arthroplasty: a systematic review
    Filippo Migliorini
    Nicola Maffulli
    Luise Schäfer
    Francesco Simeone
    Andreas Bell
    Ulf Krister Hofmann
    [J]. Knee Surgery & Related Research, 36
  • [8] Defining the Minimal Clinically Important Difference and Patient-acceptable Symptom State Score for Disability Assessment in Surgical Patients
    Shulman, Mark A.
    Kasza, Jessica
    Myles, Paul S.
    [J]. ANESTHESIOLOGY, 2020, 132 (06) : 1362 - 1370
  • [9] The Forgotten Joint Score patient-acceptable symptom state following primary total hip arthroplasty
    Singh, V
    Bieganowski, T.
    Huang, S.
    Karia, R.
    Davidovitch, R., I
    Schwarzkopf, R.
    [J]. BONE & JOINT OPEN, 2022, 3 (04): : 307 - 313
  • [10] Changes and thresholds in the Oxford Shoulder Score following shoulder arthroplasty: Minimal clinically important difference, minimal important and detectable changes, and patient-acceptable symptom state
    Liu, Perry
    Afzal, Irrum
    Asopa, Vipin
    Clement, Nick D.
    Patel, Vipul
    [J]. SHOULDER & ELBOW, 2023,